D-dimer and Factor XIII activation peptide in cerebral venous thrombosis (CVT)

Completed

• Conditions: Cerebral Venous Sinus Thrombosis(CVST); Sinus thrombosis; Cerebral Venous Thrombosis(CVT); 10007963

• Registration Number: NL-OMON43567
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 520

Inclusion Criteria

Any adult patient with a clinical suspicion of CVT where the treating neurologist considers radiological investigation (CT-V or MR-V) to be required

Exclusion Criteria

none

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Plasma D-dimer and AP-FXIII levels analyzed according to newly developed highly<br /><br>sensitive and specific ELISA methods in patients with CVT and only suspicion of<br /><br>CVT.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-overall frequency of CVT in patients with clinical suspicion of CVT<br /><br>-overall frequency of other diseases in patients with clinical suspicion of CVT<br /><br>-site of involved veins and sinus in patients with CVT</p><br>